Lung tumors are a leading cause of cancer-related death worldwide. Lung cancers are highly heterogeneous on their phenotypes, both at the cellular and molecular levels. Efforts to better understand the biological origins and outcomes of lung cancer in terms of this enormous variability often require of high-throughput experimental techniques paired with advanced data analytics. Anticipated advancements in multi-omic methodologies hold potential to reveal a broader molecular perspective of these tumors. This study introduces a theoretical and computational framework for generating network models depicting regulatory constraints on biological functions in a semi-automated way. The approach successfully identifies enriched functions in analyze...
Deep sequencing techniques provide a remarkable opportunity for comprehensive understanding of tumor...
Non-small-cell lung cancer (NSCLC) is considered as one of the malignant cancers that causes prematu...
Lung cancer is the leading cause of cancer death in Canada and worldwide. A late stage of diagnosis ...
Lung tumors are a leading cause of cancer-related death worldwide. Lung cancers are highly heterogen...
Lung tumors are a leading cause of cancer-related death worldwide. Lung cancers are highly heterogen...
Lung tumors are a leading cause of cancer-related death worldwide. Lung cancers are highly heterogen...
Lung tumors are a leading cause of cancer-related death worldwide. Lung cancers are highly heterogen...
BackgroundNon-small cell lung cancer (NSCLC) is a malignant tumor with high mortality. Lung squamous...
BackgroundNon-small cell lung cancer (NSCLC) is a malignant tumor with high mortality. Lung squamous...
BackgroundNon-small cell lung cancer (NSCLC) is a malignant tumor with high mortality. Lung squamous...
Recent technological advancements have permitted high-throughput measurement of the human genome, ep...
While previous studies reported aberrant expression of microRNAs (miRNAs) in non-small cell lung can...
Abstract Background Lung cancer is a very heterogeneous disease that can be pathologically classifie...
PurposeLung adenocarcinoma (LUAD) is a common type of lung cancer. Cancer in a small number of patie...
Multi-omic approaches are expected to deliver a broader molecular view of cancer. However, the promi...
Deep sequencing techniques provide a remarkable opportunity for comprehensive understanding of tumor...
Non-small-cell lung cancer (NSCLC) is considered as one of the malignant cancers that causes prematu...
Lung cancer is the leading cause of cancer death in Canada and worldwide. A late stage of diagnosis ...
Lung tumors are a leading cause of cancer-related death worldwide. Lung cancers are highly heterogen...
Lung tumors are a leading cause of cancer-related death worldwide. Lung cancers are highly heterogen...
Lung tumors are a leading cause of cancer-related death worldwide. Lung cancers are highly heterogen...
Lung tumors are a leading cause of cancer-related death worldwide. Lung cancers are highly heterogen...
BackgroundNon-small cell lung cancer (NSCLC) is a malignant tumor with high mortality. Lung squamous...
BackgroundNon-small cell lung cancer (NSCLC) is a malignant tumor with high mortality. Lung squamous...
BackgroundNon-small cell lung cancer (NSCLC) is a malignant tumor with high mortality. Lung squamous...
Recent technological advancements have permitted high-throughput measurement of the human genome, ep...
While previous studies reported aberrant expression of microRNAs (miRNAs) in non-small cell lung can...
Abstract Background Lung cancer is a very heterogeneous disease that can be pathologically classifie...
PurposeLung adenocarcinoma (LUAD) is a common type of lung cancer. Cancer in a small number of patie...
Multi-omic approaches are expected to deliver a broader molecular view of cancer. However, the promi...
Deep sequencing techniques provide a remarkable opportunity for comprehensive understanding of tumor...
Non-small-cell lung cancer (NSCLC) is considered as one of the malignant cancers that causes prematu...
Lung cancer is the leading cause of cancer death in Canada and worldwide. A late stage of diagnosis ...